Analysis Of Income And Expense [Abstract]

Isofol Medical - Filing #701189

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	22 407 SEK	—	—	37 119 SEK
Material income and expense [abstract]
Finance income (cost)	4 215 SEK	—	—	2 497 SEK
Revenue and other operating income	22 407 SEK	—	—	37 137 SEK
Operating expense	226 872 SEK	—	—	22 3 6 31 SEK
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense	27 721 SEK	—	—	22 740 SEK
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	1 596 SEK	—	—	1 770 SEK
Other expenses, by nature	196 712 SEK	—	—	199 535 SEK
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	200 251 SEK	20 0 251 SEK	188 992 SEK	188 992 SEK